Memory formation and retention are affected in adult miR-132/212 knockout mice

Behavioural Brain Research

Volumn 287, Issue , 2015, Pages 15-26

  Hernandez Rapp, Julia ^a,b   Smith, Pascal Y ^a,b   Filali, Mohammed ^a   Goupil, Claudia ^a,b   Planel, Emmanuel ^a,b   Magill, Stephen T ^c   Goodman, Richard H ^c   Hébert, Sébastien S ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cognitive deficit; CREB, Alzheimer's disease; Dementia; MiR 132; MiR 212

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; MICRORNA; MICRORNA 132; MICRORNA 212; UNCLASSIFIED DRUG; MIRN132 MICRORNA, MOUSE; MIRN212 MICRORNA, MOUSE;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTHROPOMETRY; ARTICLE; BARNES MAZE TEST; BODY POSITION; BRAIN CORTEX; BREATHING RATE; CEREBELLUM; COGNITION; CONTROLLED STUDY; CORNEA REFLEX; CORPUS STRIATUM; ELEVATED PLUS MAZE TEST; EXPERIMENTAL BEHAVIORAL TEST; FEAR; FEMALE; GAIT; GRIP STRENGTH; HIPPOCAMPUS; IRRITABILITY; KNOCKOUT MOUSE; LACRIMATION; LEARNING; LOCOMOTION; MALE; MEMORY CONSOLIDATION; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; OLFACTORY BULB; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REFLEX; SMITHKLINE BEECHAM HARWELL IMPERIAL COLLEGE ROYAL LONDON HOSPITAL PHENOTYPE ASSESSMENT; SPATIAL MEMORY; STARTLE REFLEX; T-MAZE TEST; TREMOR; VOCALIZATION; WESTERN BLOTTING; ANIMAL; ANXIETY; C57BL MOUSE; GENETICS; LONG TERM MEMORY; MAZE TEST; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RECOGNITION;

ANIMALS; ANXIETY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; MALE; MAZE LEARNING; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MOTOR ACTIVITY; PHOSPHORYLATION; RECOGNITION (PSYCHOLOGY); RETENTION (PSYCHOLOGY); SPATIAL MEMORY;

EID: 84925935063     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.03.032     Document Type: Article

References (72)

1. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 2004, 5:R13.
2. Ziats M.N., Rennert O.M. Identification of differentially expressed microRNAs across the developing human brain. Mol Psychiatry 2014, 19:848-852.
3. Ambros V. MicroRNAs and developmental timing. Curr Opin Genet Dev 2011, 21:511-517.
4. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
5. Thomas M., Lieberman J., Lal A. Desperately seeking microRNA targets. Nat Struct Mol Biol 2010, 17:1169-1174.
6. Dorval V., Smith P.Y., Delay C., Calvo E., Planel E., Zommer N., et al. Gene network and pathway analysis of mice with conditional ablation of Dicer in post-mitotic neurons. PLoS ONE 2012, 7:e44060.
7. Konopka W., Schutz G., Kaczmarek L. The microRNA contribution to learning and memory. Neuroscientist 2011, 17:468-474.
8. Kosik K.S. The neuronal microRNA system. Nat Rev Neurosci 2006, 7:911-920.
9. Fineberg S.K., Kosik K.S., Davidson B.L. MicroRNAs potentiate neural development. Neuron 2009, 64:303-309.
10. Magill S.T., Cambronne X.A., Luikart B.W., Lioy D.T., Leighton B.H., Westbrook G.L., et al. MicroRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc Natl Acad Sci USA 2010, 107:20382-20387.
11. Tognini P., Pizzorusso T. MicroRNA212/132 family: molecular transducer of neuronal function and plasticity. Int J Biochem Cell Biol 2012, 44:6-10.
12. Vo N., Klein M.E., Varlamova O., Keller D.M., Yamamoto T., Goodman R.H., et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci USA 2005, 102:16426-16431.
13. Wayman G.A., Davare M., Ando H., Fortin D., Varlamova O., Cheng H.Y., et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci USA 2008, 105:9093-9098.
14. Lambert T.J., Storm D.R., Sullivan J.M. MicroRNA132 modulates short-term synaptic plasticity but not basal release probability in hippocampal neurons. PLoS ONE 2010, 5:e15182.
15. Remenyi J., van den Bosch M.W., Palygin O., Mistry R.B., McKenzie C., Macdonald A., et al. miR-132/212 knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity. PLoS ONE 2013, 8:e62509.
16. Luikart B.W., Bensen A.L., Washburn E.K., Perederiy J.V., Su K.G., Li Y., et al. miR-132 mediates the integration of newborn neurons into the adult dentate gyrus. PLoS ONE 2011, 6:e19077.
17. Nudelman A.S., DiRocco D.P., Lambert T.J., Garelick M.G., Le J., Nathanson N.M., et al. Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus 2010, 20:492-498.
18. Hansen K.F., Sakamoto K., Wayman G.A., Impey S., Obrietan K. Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory. PLoS ONE 2010, 5:e15497.
19. Hansen K.F., Karelina K., Sakamoto K., Wayman G.A., Impey S., Obrietan K. miRNA-132: a dynamic regulator of cognitive capacity. Brain Struct Funct 2013, 218:817-831.
20. Wang R.Y., Phang R.Z., Hsu P.H., Wang W.H., Huang H.T., Liu I.Y. In vivo knockdown of hippocampal miR-132 expression impairs memory acquisition of trace fear conditioning. Hippocampus 2013, 23:625-633.
21. Wanet A., Tacheny A., Arnould T., Renard P. miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res 2012, 40:4742-4753.
22. Hebert S.S., Wang W.X., Zhu Q., Nelson P.T. A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J Alzheimers Dis 2013, 35:335-348.
23. Cogswell J.P., Ward J., Taylor I.A., Waters M., Shi Y., Cannon B., et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008, 14:27-41.
24. Wong H.K., Veremeyko T., Patel N., Lemere C.A., Walsh D.M., Esau C., et al. De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease. Human Mol Genet 2013, 22:3077-3092.
25. Lau P., Frigerio C.S., De Strooper B. Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: the need of larger datasets. Ageing Res Rev 2014, 17:43-53.
26. Packer A.N., Xing Y., Harper S.Q., Jones L., Davidson B.L. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci 2008, 28:14341-14346.
27. Johnson R., Zuccato C., Belyaev N.D., Guest D.J., Cattaneo E., Buckley N.J. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis 2008, 29:438-445.
28. Burgos K., Malenica I., Metpally R., Courtright A., Rakela B., Beach T., et al. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology. PLoS ONE 2014, 9:e94839.
29. Chen-Plotkin A.S., Unger T.L., Gallagher M.D., Bill E., Kwong L.K., Volpicelli-Daley L., et al. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. J Neurosci 2012, 32:11213-11227.
30. Smith P.Y., Delay C., Girard J., Papon M.A., Planel E., Sergeant N., et al. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Human Mol Genet 2011, 20:4016-4024.
31. Filali M., Lalonde R. Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease. Brain Res 2009, 1292:93-99.
32. Filali M., Lalonde R., Theriault P., Julien C., Calon F., Planel E. Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav Brain Res 2012, 234:334-342.
33. Terzian A.L., Drago F., Wotjak C.T., Micale V. The dopamine and cannabinoid interaction in the modulation of emotions and cognition: assessing the role of cannabinoid CB1 receptor in neurons expressing dopamine D1 receptors. Front Behav Neurosci 2011, 5:49.
34. Walker J.M., Fowler S.W., Miller D.K., Sun A.Y., Weisman G.A., Wood W.G., et al. Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease. Behav Brain Res 2011, 222:169-175.
35. Filali M., Lalonde R. The effects of subchronic d-serine on left-right discrimination learning, social interaction, and exploratory activity in APPswe/PS1 mice. Eur J Pharmacol 2013, 701:152-158.
36. Klein M.E., Lioy D.T., Ma L., Impey S., Mandel G., Goodman R.H. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci 2007, 10:1513-1514.
37. Remenyi J., Hunter C.J., Cole C., Ando H., Impey S., Monk C.E., et al. Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins. Biochem J 2010, 428:281-291.
38. Im H.I., Hollander J.A., Bali P., Kenny P.J. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 2010, 13:1120-1127.
39. Wang W., Kwon E.J., Tsai L.H. MicroRNAs in learning, memory, and neurological diseases. Learn Mem 2012, 19:359-368.
40. Mellios N., Sugihara H., Castro J., Banerjee A., Le C., Kumar A., et al. miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity. Nat Neurosci 2011, 14:1240-1242.
41. Vidigal J.A., Ventura A. The biological functions of miRNAs: lessons from in vivo studies. Trends Cell Biol 2015, 25:137-147.
42. Nunez Y.O., Truitt J.M., Gorini G., Ponomareva O.N., Blednov Y.A., Harris R.A., et al. Positively correlated miRNA-mRNA regulatory networks in mouse frontal cortex during early stages of alcohol dependence. BMC Genomics 2013, 14:725.
43. Ritchie W., Rajasekhar M., Flamant S., Rasko J.E. Conserved expression patterns predict microRNA targets. PLoS Comput Biol 2009, 5:e1000513.
44. Kida S., Serita T. Functional roles of CREB as a positive regulator in the formation and enhancement of memory. Brain Res Bull 2014, 105:17-24.
45. Li H., Zhong X., Chau K.F., Williams E.C., Chang Q. Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory. Nat Neurosci 2011, 14:1001-1008.
46. Heldt S.A., Stanek L., Chhatwal J.P., Ressler K.J. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 2007, 12:656-670.
47. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997, 94:13287-13292.
48. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 2001, 276:21562-21570.
49. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
50. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
51. Heneka M.T., Ramanathan M., Jacobs A.H., Dumitrescu-Ozimek L., Bilkei-Gorzo A., Debeir T., et al. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 2006, 26:1343-1354.
52. Ambree O., Richter H., Sachser N., Lewejohann L., Dere E., de Souza Silva M.A., et al. Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease. Neurobiol Aging 2009, 30:1192-1204.
53. Gortz N., Lewejohann L., Tomm M., Ambree O., Keyvani K., Paulus W., et al. Effects of environmental enrichment on exploration, anxiety, and memory in female TgCRND8 Alzheimer mice. Behav Brain Res 2008, 191:43-48.
54. Clinton L.K., Billings L.M., Green K.N., Caccamo A., Ngo J., Oddo S., et al. Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis 2007, 28:76-82.
55. Oules B., Del Prete D., Greco B., Zhang X., Lauritzen I., Sevalle J., et al. Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease. J Neurosci 2012, 32:11820-11834.
56. Dumont M., Strazielle C., Staufenbiel M., Lalonde R. Spatial learning and exploration of environmental stimuli in 24-month-old female APP23 transgenic mice with the Swedish mutation. Brain Res 2004, 1024:113-121.
57. Hyde L.A., Kazdoba T.M., Grilli M., Lozza G., Brusa R., Zhang Q., et al. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice. Behav Brain Res 2005, 160:344-355.
58. Nelson R.L., Guo Z., Halagappa V.M., Pearson M., Gray A.J., Matsuoka Y., et al. Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Exp Neurol 2007, 205:166-176.
59. Carroll J.C., Rosario E.R., Chang L., Stanczyk F.Z., Oddo S., LaFerla F.M., et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 2007, 27:13357-13365.
60. Ohno M., Sametsky E.A., Younkin L.H., Oakley H., Younkin S.G., Citron M., et al. BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 2004, 41:27-33.
61. Prut L., Abramowski D., Krucker T., Levy C.L., Roberts A.J., Staufenbiel M., et al. Aged APP23 mice show a delay in switching to the use of a strategy in the Barnes maze. Behav Brain Res 2007, 179:107-110.
62. Stewart S., Cacucci F., Lever C. Which memory task for my mouse? A systematic review of spatial memory performance in the Tg2576 Alzheimer's mouse model. J Alzheimers Dis 2011, 26:105-126.
63. Yassine N., Lazaris A., Dorner-Ciossek C., Despres O., Meyer L., Maitre M., et al. Detecting spatial memory deficits beyond blindness in tg2576 Alzheimer mice. Neurobiol Aging 2013, 34:716-730.
64. Elder G.A., Gama Sosa M.A., De Gasperi R. Transgenic mouse models of Alzheimer's disease. Mt Sinai J Med 2010, 77:69-81.
65. Platt T.L., Reeves V.L., Murphy M.P. Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis. Biochim Biophys Acta 2013, 1832:1437-1448.
66. Webster S.J., Bachstetter A.D., Nelson P.T., Schmitt F.A., Van Eldik L.J. Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet 2014, 5:88.
67. Clement Y., Joubert C., Kopp C., Lepicard E.M., Venault P., Misslin R., et al. Anxiety in mice: a principal component analysis study. Neural Plast 2007, 2007:35457.
68. Meshorer E., Soreq H. Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci 2006, 29:216-224.
69. Shaltiel G., Hanan M., Wolf Y., Barbash S., Kovalev E., Shoham S., et al. Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target. Brain Struct Funct 2013, 218:59-72.
70. Taylor T.N., Greene J.G., Miller G.W. Behavioral phenotyping of mouse models of Parkinson's disease. Behav Brain Res 2010, 211:1-10.
71. Menalled L., El-Khodor B.F., Patry M., Suarez-Farinas M., Orenstein S.J., Zahasky B., et al. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol Dis 2009, 35:319-336.
72. Heikkinen T., Lehtimaki K., Vartiainen N., Puolivali J., Hendricks S.J., Glaser J.R., et al. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease. PLoS ONE 2012, 7:e50717.